# Philip A. Philip

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/philip-a-philip/

## Facts

| Field | Value |
| --- | --- |
| Citations | 18,503 |
| Field | Pancreatic and Hepatic Oncology Research |
| h-index | 71 |
| i10-index | 178 |
| Last Known Institution | Henry Ford Health System |
| OpenAlex ID | https://openalex.org/A5011817630 |
| ORCID iD | https://orcid.org/0000-0002-6513-3491 |
| Works | 408 |

## Researcher papers

- [Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study](https://scholariq.org/papers/brivanib-versus-sorafenib-as-first-line-therapy-in-patients-with-unresectable/)

## Researcher topics

- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [MicroRNA in disease regulation](https://scholariq.org/topics/microrna-in-disease-regulation/)
- [Neuroendocrine Tumor Research Advances](https://scholariq.org/topics/neuroendocrine-tumor-research-advances/)

## Researcher university

- [Henry Ford Health System](https://scholariq.org/institutions/henry-ford-health-system/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.